Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,910.00
+90.00 (1.55%)
Sep 4, 2026, 3:30 PM KST

Tdspharm Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,7601,2134,7041,6362,9371,622
Short-Term Investments
24,99919,00026,00013,5007,0006,500
Cash & Short-Term Investments
27,75920,21330,70415,1369,9378,122
Cash Growth
-4.22%-34.17%102.86%52.32%22.34%10.66%
Accounts Receivable
4,9496,4445,1826,5755,5963,013
Other Receivables
338.88289.86480.95230.7102.731.39
Receivables
5,4336,8795,7436,8065,6993,014
Inventory
3,9772,5973,1512,4932,1631,939
Prepaid Expenses
20.2523.316.678.538.7510.66
Other Current Assets
103.09103.624.6136.15142.1447.95
Total Current Assets
37,29329,81639,64024,48017,95013,134
Property, Plant & Equipment
20,85220,7298,8818,9179,70510,207
Long-Term Investments
2,10454.47--1,9693,384
Other Intangible Assets
111.46130.217351.54-0-0
Long-Term Deferred Tax Assets
130.23154.32162.43207.95493.84-
Long-Term Deferred Charges
68.1183.82115.26146.69157.17151.67
Other Long-Term Assets
3,1543,184188.95167.01193.5490.16
Total Assets
63,71354,15249,16133,97030,46926,967

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2,6782,2651,5432,2662,2201,249
Accrued Expenses
616.72109.5868.373.6175.0445.56
Short-Term Debt
13,8007,5946,0006,0006,0007,000
Current Portion of Long-Term Debt
--775200--
Current Portion of Leases
55.1955.0279.1675.74102.249.82
Current Income Taxes Payable
414.76343.311,078273.57411.92408.58
Other Current Liabilities
1,105839.6974.031,1761,021832.78
Total Current Liabilities
18,67011,20610,51710,0659,8309,585
Long-Term Debt
---775675-
Long-Term Leases
37.4562.4972.0494.7173.8990.34
Pension & Post-Retirement Benefits
---35.371,4211,094
Long-Term Deferred Tax Liabilities
-----23.19
Other Long-Term Liabilities
116.0297.9867.0355.0559.9131.22
Total Liabilities
18,82311,36710,65611,02512,16010,824

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
553553553500500500
Additional Paid-In Capital
3,4929,9709,970---
Retained Earnings
42,15133,56829,29425,73621,26017,804
Treasury Stock
-881.35-881.35-881.35-2,706-2,706-2,706
Comprehensive Income & Other
-425.07-425.07-431.07-584.88-745.34544.66
Shareholders' Equity
44,89042,78538,50422,94518,30816,143
Total Liabilities & Equity
63,71354,15249,16133,97030,46926,967

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
13,8937,7126,9267,1456,9517,140
Net Cash (Debt)
13,86712,50123,7787,9912,986982.27
Net Cash Growth
-37.11%-47.43%197.58%167.60%203.99%249.25%
Net Cash Per Share
2620.052363.855135.781876.65700.7910630.51
Filing Date Shares Outstanding
5.35.295.294.264.260.09
Total Common Shares Outstanding
5.35.295.294.264.260.09
Working Capital
18,62318,60929,12314,4148,1203,549
Book Value Per Share
8472.258090.157280.755388.684296.83174704.28
Tangible Book Value
44,77942,65538,33122,89318,30816,143
Tangible Book Value Per Share
8451.228065.537248.045376.584296.83174704.29
Land
10,49710,4972,0202,0202,0202,020
Buildings
11,0048,5897,4207,5317,5317,531
Machinery
8,0538,0289,1148,5998,4578,088
Construction In Progress
35.52,040231.19190.08127.21-